Menu
Recruiting NCT06420752

Passive Stretching in Peripheral Arterial Disease Patients

Phase II Interventional Peripheral Arterial Disease Walking, Difficulty Inflammation

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Calf Plantar flexion, Dietary nitrate.
Who it may be relevant to
Registry conditions: Peripheral Arterial Disease, Walking, Difficulty, Inflammation. Basic parameters: 40 years — 90 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Passive Stretching and Dietary Nitrate Rescue Functional Capacity in Peripheral Arterial Disease

Overview

Peripheral artery disease (PAD) leads to higher mortality rates and strains healthcare systems due to increased costs. It causes leg pain during walking due to reduced blood flow. Nitric oxide (NO) deficiency contributes to vascular issues in PAD, with few effective treatments available. Passive calf muscle stretching boosts NO levels, vascular health, and walking ability in PAD patients. However, the inflammatory processes underlying these improvements are unclear. This study aims to track inflammatory markers and cardiovascular changes during 12 weeks of passive stretching. Additionally, combining stretching with dietary nitrate could further enhance walking capacity by reducing reactive oxygen species. The study will monitor inflammation, vascular function, and oxidative capacity to understand the effects on functional ability in PAD patients. This research is crucial for improving physical function and addressing exercise intolerance in PAD.

Interventions

  • Device Calf Plantar flexion
    Daily passive calf stretching
  • Dietary supplement Dietary nitrate
    Weekday 140 ml dietary nitrate consumption two hours prior to passive stretching

Primary outcome measures

  • Functional capacity [Time frame: 12-14 weeks]
Secondary outcome measures (2)
  • Inflammatory markers [Time frame: 12-14 weeks]
  • Vascular function [Time frame: 12-14 weeks]

Eligibility criteria

Inclusion criteria

Ankle-brachial index of 0.90 or less Stable condition for at least 3 months

Exclusion criteria

Habitual exercise or cardiovascular rehabilitation program during the past 3 months Critical limb ischemia, amputation, or leg pain at rest Major surgery or lower extremity revascularization in the last 3 months Heart Failure Kidney disease Beet allergy Crohn's Current smoker

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Double blind
Primary purpose
Treatment

Study locations

United States · 1 center
  • University of Wisconsin La Crosse — La Crosse

Identifiers

NCT: NCT06420752 · 232-JC-230.2

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗